NCT06470035
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Stopped Withdrawn before enrolling Sponsor's reason: The study was withdrawn prior to initiation. No participants were enrolled. Show 5 more changesShow less
- Enrollment target: estimated 170 to confirmed 0
- Start date: Apr 2025 to Jan 6, 2027
- Eligibility criteria expanded, about 40 words
- Secondary endpoints: details revised at 5 of 5 entries
- Site contacts updated at 2 of 2 sites
- Minor Study sites revised (2)v4
- Notable Primary and study completion dates: Dec 2025 to Apr 2027
- Start date: Jan 2025 to Apr 2025
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
The active device utilizes a technology termed vestibular nerve stimulation (VeNS). The device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 30 minutes per day.
The sham device looks identical to the active device and interacts with the app in a similar manner to the active device. The device will be placed on the head in a manner analogous to headphones with hydrogel electrodes placed over the mastoid processes. Participants will be advised to use the device at home for 30 minutes per day.
Devices: Active VeNS Device, Sham VeNS Device
Sites
2 sites in 2 countries
United Kingdom 1, United States 1